Max Healthcare Institute profit and loss

Latest FY26

Revenue: ₹8,373cr+19.1% on FY25
EBITDA: ₹2,243cr+21.3% on FY25
Net profit: ₹1,442cr+34.1% on FY25
EPS: ₹14.83+34.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	8,712	8,373	7,028	5,406	4,563	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	167	163	156	178	139
	8,879	8,536	7,184	5,584	4,702
	1,866	1,799	1,496	1,119	937
	−7.9	−8.7	−19.4	−0.5	−14.9
	1,407	1,357	1,174	934	809
	251	235	165	59.9	83.9
	474	447	359	245	232
	3,128	2,983	2,529	1,861	1,591
	7,119	6,812	5,704	4,219	3,638
	2,318	2,243	1,849	1,492	1,241
	1,844	1,796	1,489	1,247	1,008
Profit
	1,760	1,724	1,480	1,365	1,064
	−48.2	−48.2	−73.6	0.0	0.0
	1,711	1,676	1,406	1,365	1,064
	197	211	336	271	205
	56.7	21.9	−5.6	36.4	−245
	254	233	330	308	−39.8
	1,457	1,442	1,076	1,058	1,104
	1,457	1,442	1,076	1,058	1,104
	−3.6	−1.6	−4.6	−6.5	−0.5
	1,454	1,441	1,071	1,051	1,103
	—	—	—	1,051	1,104
Per share
	₹14.99	₹14.83	₹11.07	₹10.89	₹11.38
	₹14.91	₹14.76	₹11.01	₹10.84	₹11.36
Other comprehensive income — detail
	−3.6	−1.6	−4.6	—	—
	1.7	−1.8	−5.1	−6.8	−0.1
	0.8	0.0	−0.8	—	—
	—	—	−0.8	−0.8	0.3
	−6.2	0.3	−0.3	−0.5	−0.1
	−1.6	0.0	0.0	—	—
	—	—	—	0.0	0.1
	—	—	—	—	1,104
Per share — as-filed variants
	₹14.99	₹14.83	₹11.07	₹10.89	₹11.38
	₹14.91	₹14.76	₹11.01	₹10.84	₹11.36
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	6,854	6,583	5,551	4,288	3,641
	78.7%	78.6%	79.0%	79.3%	79.8%
Adjusted (ex-exceptional items) — derived
	1,760	1,724	1,480	1,365	1,064
	−48.2	−48.2	−73.6	0.0	0.0
	1,498	1,484	1,132	1,058	1,104
	₹15.41	₹15.26	₹11.65	₹10.89	₹11.38

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MAXHEALTH₹851.50

Max Healthcare Institute Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersAPOLLOHOSP FORTIS MEDANTA DRREDDY CIPLA SUNPHARMA DIVISLAB TORNTPHARMMcap ₹82,862 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	4,562.6	5,406.0	7,028.5	8,373.5	8,712.1
Other Income	139.2	178.1	155.6	162.6	166.6
Total Income	4,701.8	5,584.1	7,184.1	8,536.1	8,878.7
Expenses
+ Purchases of Stock-in-Trade	936.9	1,119.0	1,496.4	1,798.8	1,866.1
+ Changes in Inventories	-14.9	-0.5	-19.4	-8.7	-7.9
+ Employee Benefit Expense	809.4	934.4	1,174.0	1,357.1	1,407.2
+ Finance Costs	83.9	59.9	165.0	235.1	251.3
+ Depreciation & Amortisation	232.2	245.0	359.4	446.5	474.1
+ Other Expenses	1,590.7	1,861.0	2,528.6	2,983.5	3,128.3
Total Expenses	3,638.1	4,218.8	5,704.1	6,812.3	7,119.0
EBITDA	1,240.5	1,492.1	1,848.8	2,242.8	2,318.4
EBIT	1,008.3	1,247.1	1,489.4	1,796.3	1,844.3
Profit
PBT before Exceptional Items	1,063.7	1,365.3	1,480.0	1,723.8	1,759.7
+ Exceptional Items	0.0	0.0	-73.6	-48.2	-48.2
Pretax Income	1,063.7	1,365.3	1,406.4	1,675.6	1,711.5
+ Current Tax	204.8	271.3	336.1	211.3	197.3
+ Deferred Tax	-244.6	36.4	-5.6	21.9	56.7
Tax Expense	-39.8	307.7	330.5	233.2	254.1
Net Income	1,103.5	1,057.6	1,075.9	1,442.4	1,457.4
+ Net Income — Continuing Ops	1,103.5	1,057.6	1,075.9	1,442.4	1,457.4
+ Other Comprehensive Income	-0.5	-6.5	-4.6	-1.6	-3.6
Total Comprehensive Income	1,103.0	1,051.2	1,071.3	1,440.8	1,453.8
Net Income to Common	1,103.5	1,051.2	—	—	—
Per Share
Basic EPS	11.38	10.89	11.07	14.83	14.99
Diluted EPS	11.36	10.84	11.01	14.76	14.91
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-4.6	-1.6	-3.6
+ Items NOT to be Reclassified to P&L	-0.1	-6.8	-5.1	-1.8	1.7
+ Tax on Items NOT to be Reclassified	—	—	-0.8	0.0	0.8
+ Tax on Items NOT to be Reclassified — alt tag	0.3	-0.8	-0.8	—	—
+ Items to be Reclassified to P&L	-0.1	-0.5	-0.3	0.3	-6.2
+ Tax on Items to be Reclassified	—	—	0.0	0.0	-1.6
+ Tax on Items to be Reclassified — alt tag	0.1	0.0	—	—	—
Comprehensive Income — Owners of Parent	1,103.5	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	11.38	10.89	11.07	14.83	14.99
Diluted EPS — Continuing Operations	11.36	10.84	11.01	14.76	14.91
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	3,640.6	4,287.5	5,551.4	6,583.4	6,853.9
Gross Margin %	79.79	79.31	78.98	78.62	78.67
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	1,063.7	1,365.3	1,480.0	1,723.8	1,759.7
− Exceptional Items (reconciliation)	0.0	0.0	-73.6	-48.2	-48.2
Net Income Adj (tax-effected)	1,103.5	1,057.6	1,132.2	1,483.9	1,498.5
EPS Adj	11.38	10.89	11.65	15.26	15.41
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	970.9	971.9	972.1	973.1	973.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.